• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估头颈部鳞状细胞癌患者肿瘤缺氧情况的氟-18-氟米索硝唑正电子发射断层扫描/计算机断层扫描的最佳时机

Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma.

作者信息

Chatterjee Abhishek, Gupta Tejpal, Rangarajan Venkatesh, Purandare Nilendu, Kunder Shreya, Murthy Vedang, Budrukkar Ashwini, Ghosh-Laskar Sarbani, Agarwal JaiPrakash

机构信息

Departments of Radiation Oncology.

Nuclear Medicine and Molecular Imaging, ACTREC/TMH, Tata Memorial Centre, Mumbai, India.

出版信息

Nucl Med Commun. 2018 Sep;39(9):859-864. doi: 10.1097/MNM.0000000000000878.

DOI:10.1097/MNM.0000000000000878
PMID:29939883
Abstract

OBJECTIVES

The aim of this study was to identify the optimal timing of fluorine-18-fluoromisonidazole (F-MISO) PET/CT imaging to assess hypoxia in patients with head and neck squamous cell carcinoma.

PATIENTS AND METHODS

Eighteen patients underwent pretreatment F-MISO PET/CT imaging after providing written informed consent. PET scans were acquired at 1, 3, and 5 h after injection of the radionuclide. The mean standardized uptake value (SUV) within a spherical region of interest placed on the contralateral neck musculature at the level of the largest tumor dimension was labeled as background. A value 1.5 times the background was deemed the threshold for significant hypoxia. Using this threshold, volumetric regions of interest encompassing the tumor were placed and hypoxic tumor volume (HTV) was generated for the primary tumor. Repeated-measures analysis of variance was used to compare the F-MISO PET/CT metrics across the three time-points. The volume of the primary tumor was also correlated with HTV.

RESULTS

The mean SUV of the background decreased consistently over time, resulting in increased focality of F-MISO uptake in the tumor tissues. Analysis of variance showed statistically significant differences in the mean SUV measurements of the background between the 1-h and the 3-h time-points (P=0.034) as well as the 1-h and the 5-h time-points (P=0.034). In parallel, the mean HTV increased from 1.72 cm at 1 h after injection to 6.52 cm at 3 h and further to 7.24 cm at 5 h, with a statistically significant difference between the 1-h and the 3-h scans (P=0.023) and the 1-h and the 5-h scans (P=0.023). There was a moderately good positive correlation between gross tumor volume on planning computed tompography (CT) and HTV at 3 h on the F-MISO scan (Pearson's correlation co-efficient 'r'=+0.753; P<0.0001).

CONCLUSION

The contrast resolution of F-MISO PET/CT scans in head and neck squamous cell carcinoma is suboptimal with early image acquisition, but improves significantly after delayed imaging. Increasing volume of tumor at the primary site is associated with an increase in hypoxia.

摘要

目的

本研究旨在确定18F-氟米索硝唑(F-MISO)PET/CT成像评估头颈部鳞状细胞癌患者缺氧情况的最佳时机。

患者与方法

18例患者在签署书面知情同意书后接受了治疗前F-MISO PET/CT成像检查。在注射放射性核素后1、3和5小时进行PET扫描。将置于对侧颈部肌肉组织、最大肿瘤层面处的球形感兴趣区内的平均标准化摄取值(SUV)标记为背景值。背景值的1.5倍被视为显著缺氧的阈值。利用该阈值,放置包含肿瘤的体积感兴趣区,并生成原发肿瘤的缺氧肿瘤体积(HTV)。采用重复测量方差分析比较三个时间点的F-MISO PET/CT指标。原发肿瘤体积也与HTV相关。

结果

背景的平均SUV随时间持续下降,导致肿瘤组织中F-MISO摄取的局灶性增加。方差分析显示,1小时和3小时时间点之间(P = 0.034)以及1小时和5小时时间点之间(P = 0.034)背景的平均SUV测量值存在统计学显著差异。同时,平均HTV从注射后1小时的1.72 cm增加到3小时的6.52 cm,并进一步增加到5小时的7.24 cm,1小时和3小时扫描之间(P = 0.023)以及1小时和5小时扫描之间(P = 0.023)存在统计学显著差异。计划计算机断层扫描(CT)上的肿瘤总体积与F-MISO扫描3小时时的HTV之间存在中度良好的正相关(Pearson相关系数“r”= +0.753;P < 0.0001)。

结论

头颈部鳞状细胞癌中,早期图像采集时F-MISO PET/CT扫描的对比分辨率欠佳,但延迟成像后显著改善。原发部位肿瘤体积增加与缺氧增加相关。

相似文献

1
Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma.用于评估头颈部鳞状细胞癌患者肿瘤缺氧情况的氟-18-氟米索硝唑正电子发射断层扫描/计算机断层扫描的最佳时机
Nucl Med Commun. 2018 Sep;39(9):859-864. doi: 10.1097/MNM.0000000000000878.
2
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.头颈部鳞状细胞癌定量成像参数的评估。
Q J Nucl Med Mol Imaging. 2022 Jun;66(2):162-170. doi: 10.23736/S1824-4785.19.03179-0. Epub 2019 Sep 5.
3
Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with F-Fluoromisonidazole-PET/CT.评估 F-氟咪索硝唑-PET/CT 缺氧成像的最佳注射后时间。
Mol Imaging Biol. 2021 Aug;23(4):597-603. doi: 10.1007/s11307-021-01580-6. Epub 2021 Jan 21.
4
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.18F-氟咪索硝唑 PET 评估头颈部肿瘤缺氧的高重复性。
J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.
5
Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.头颈部放化疗期间缺氧PET成像与组织生物标志物之间的关系分析
Acta Oncol. 2016 Nov;55(11):1299-1304. doi: 10.1080/0284186X.2016.1219046. Epub 2016 Sep 3.
6
Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.在非小细胞肺癌(NSCLC)患者中,在放疗前和放疗期间同时进行¹⁸F-氟代脱氧葡萄糖(FDG)代谢、¹⁸F-氟代胸腺嘧啶(FLT)增殖和¹⁸F- 米妥唑胺(F-miso)缺氧的正电子发射断层扫描(PET)评估:一项初步研究。
Radiother Oncol. 2011 Jan;98(1):109-16. doi: 10.1016/j.radonc.2010.10.011. Epub 2010 Nov 4.
7
Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.头颈部癌患者中高氟代脱氧葡萄糖摄取(FDG-avid)和氟米索(FMISO)低氧肿瘤亚体积的重叠情况。
Acta Oncol. 2017 Nov;56(11):1577-1582. doi: 10.1080/0284186X.2017.1363910. Epub 2017 Aug 29.
8
Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer.在三示踪剂18F-氟脱氧葡萄糖-18F-氟胸腺嘧啶核苷-18F-氟米索硝唑-PET/CT研究中测量的肿瘤生物学状态与头颈癌患者人乳头瘤病毒状态之间的相关性。
Nucl Med Commun. 2019 Jul;40(7):752-757. doi: 10.1097/MNM.0000000000001016.
9
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.氟-18标记的氟米索硝唑正电子发射断层扫描与计算机断层扫描引导的调强放射治疗用于头颈癌:一项可行性研究。
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):2-13. doi: 10.1016/j.ijrobp.2007.06.039. Epub 2007 Sep 14.
10
18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.治疗前 18F-氟咪索硝唑正电子发射断层扫描是头颈部鳞状细胞癌患者放疗结果和生存预后的预测因子。
Ann Nucl Med. 2011 Nov;25(9):625-33. doi: 10.1007/s12149-011-0508-9. Epub 2011 Jul 1.

引用本文的文献

1
Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer - A scoping review.使用正电子发射断层扫描(PET)成像技术在头颈癌中研究缺氧与肿瘤体积的关系——一项范围综述
Clin Transl Radiat Oncol. 2022 Jun 15;36:40-46. doi: 10.1016/j.ctro.2022.06.004. eCollection 2022 Sep.
2
Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck.头颈部鳞状细胞癌中缺氧的影像学与组织生物标志物之间的相关性
World J Nucl Med. 2021 Aug 20;20(3):228-236. doi: 10.4103/wjnm.WJNM_91_20. eCollection 2021 Jul-Sep.
3
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (F-FETNIM) PET/CT and overall survival in glioma patients.
通过氟-18氟乙基硝咪唑(F-FETNIM)PET/CT测量的低氧血症与胶质瘤患者总生存期的相关性。
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1427-1434. doi: 10.1007/s00259-019-04621-z. Epub 2019 Nov 28.